Overall rank by patents
#27,220
of 49,997 tracked assignees
USPTO PatentsView assignee record - 10 granted patents across 9 technology areas, recorded in grant years 2019–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device).
The verdict
According to USPTO PatentsView, Quest ranks #27,220 of 49,997 tracked US assignees by granted-patent volume, with 10 patents across 9 technology areas.
USPTO PatentsView assignee plate
Corpus R27220 · US Corporation #27,220 · 10 grants
GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-USCORP · VEL-SURGE · BOOK-FULL
Nearest grant-volume peer: Qu Biologics Inc. (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
Qualcomm Incorporated · highest
85 score
Quest Products · this assignee
34 score
3D Lighting… · lowest
7 score
What this shows Quest's Innovation Score is 34.2/100 (47th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Quest Products, LLC is a focused PatentsView assignee: 9 CPC subclasses with 50% of grants classified under A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device). Peak complete grant year is 2019 (3 grants) versus a trough of 1 in 2020. By volume, Quest sits between Qu Biologics Inc. and R&B Leasing, LLC.
Quest Products, LLC shows 3 grants in 2022–2024 against only 5 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
Qu Biologics Inc.
10 patents
Quallion LLC
10 patents
Quantum Source Labs Ltd.
10 patents
Queen Mary & Westfield College, University of London
10 patents
Quintar, Inc.
10 patents
Quintiles IMS Incorporated
10 patents
R & D Tool & Engineering Co.
10 patents
R&B Leasing, LLC
10 patents
Quest Products, LLC
10 patents
What this shows Quest holds 10 patents at rank #27,210, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #27,210 in granted patent volume.
Other assignees with the most granted patents in Quest's primary technology class.
Quest's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
34 47th percentile higher than 47% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2019–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2019 | 3 | 30.0% |
| 2020 | 1 | 10.0% |
| 2021 | 1 | 10.0% |
| 2022 | 1 | 10.0% |
| 2023 | 1 | 10.0% |
| 2024 | 1 | 10.0% |
| 2025partial year | 2 | 20.0% |
Top 9 of 9 technology areas
Overall rank by patents
#27,220
of 49,997 tracked assignees
34.2 out of 100
What to do with this data
Quest Products, LLC's patent record in context - here's where to go next.
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.